Attorney General Marty Jackley says South Dakota will receive $419,000 from a multistate settlement with a drug company.
Pfizer has agreed to pay $35 million to resolve allegations by 42 states that a subsidiary illegally marketed an organ transplant drug for unapproved uses.
Jackley says the misleading claims put consumers' health at risk.
Authorities say Wyeth Pharmaceuticals, which Pfizer bought in 2009, trained sales representatives to encourage doctors to prescribe Rapamune for uses other than preventing rejection of transplanted kidneys.
Rapamune was approved in 1999 for use in kidney transplant patients. It's illegal to promote drugs for uses not cleared by the Food and Drug Administration.
Pfizer says the alleged activity occurred before it acquired Wyeth. The company didn't admit any wrongdoing or liability as part of the settlement.
Most Popular Today
- 1.Retail & Restaurants
Hy-Vee Announces Updates To Sioux Falls Stores
- 2.Recalls, General
Ford Recalls Nearly 423K Vehicles For Power Steering Problem
Software Glitch Can Cause iPhones To Crash
- 4.Your Money Matters
Flights Cut/Airfares Rise Out of Sioux Falls
- 5.Retail & Restaurants
Caribou Coffee, Einstein Bagels Opening SF Location
- 6.Your Money Matters
Changing Face Of 41st Street
- 7.Your Money Matters
Downtown Sioux Falls Store Featured By Google
Sioux Falls Ranked As Top City For College Grads
- 9.Gas & Energy
BNSF, Power Plant Owner Settle Long-Running Rate Dispute
- 10.Health Care
Med-Star Settling Into New Location